Page last updated: 2024-09-03

caprylates and Hematologic Malignancies

caprylates has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dralle, S; Ellis, LR; Harrelson, R; Hurd, D; Isom, S; Lee, K; Levitan, D; Luddy, J; Lyerly, S; Manuel, M; Maturo, C; Miller, LD; Pardee, TS; Powell, BL; Rodriguez, R; Stadelman, KM	1

Trials

1 trial(s) available for caprylates and Hematologic Malignancies

Article	Year
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Oct-15, Volume: 20, Issue:20 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Caprylates; Cell Line, Tumor; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia; Male; Middle Aged; Mitochondria; Neoplasm Staging; Positron-Emission Tomography; Sulfides; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2014

Article

Year

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Oct-15, Volume: 20, Issue:20

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Caprylates; Cell Line, Tumor; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia; Male; Middle Aged; Mitochondria; Neoplasm Staging; Positron-Emission Tomography; Sulfides; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2014